Anna L. Goodman

15.9k citations

55 papers · 2.2k indexed · 2 hit papers · h-index 19

Impact in

Virology top 5%
- HIV Research and Treatment
Public Health, Environmental and Occupational Health top 5%
- Malaria Research and Control
- Mosquito-borne diseases and control

Papers in

Applied Microbiology and Biotechnology 4
- Antibiotic Use and Resistance 4
Microbiology 1

Co-authors: Simon J. Draper Adrian V. S. Hill Carole A. Long Sumi Biswas Alexander D. Douglas Andrew R. Williams David Wyllie Joseph J. Illingworth
Journals: Clinical Medicine (3 papers)Infection and Immunity (2 papers)Vaccine (2 papers)Nature Communications (2 papers)American Journal of Tropical Medicine and Hygiene (2 papers)
Partner nations: United Kingdom United States Netherlands

In The Last Decade

Anna L. Goodman

49 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Nonantibiotic prevention and management of recurrent urinary tract infection 2018 · 206 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Reviews Urology
2013 Nature Communications

Peers

Countries citing papers authored by Anna L. Goodman

Since Specialization

Citations

This map shows the geographic impact of Anna L. Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L. Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L. Goodman more than expected).

Fields of papers citing papers by Anna L. Goodman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L. Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L. Goodman. The network helps show where Anna L. Goodman may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna L. Goodman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna L. Goodman Line = papers co-authored together Anna L. Goodman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Blood absolute lymphocyte count and trajectory are important in understanding severe COVID-19 BMC Infectious Diseases ·Catharine I. Paules, Ekaterina Nelidova, Kathryn Shaw‐Saliba, Judith A. Aberg, Edward M. Gardner, Anna L. Goodman, Nagalingeswaran Kumarasamy, Govind Tol, David M. Vock, Crystal M. North, Jens Lundgren, Neil R. Aggarwal, (unknown)	2025	2
2	Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic-Resistant Organisms (FERARO): A feasibility randomised controlled trial Journal of Infection ·Blair Merrick, Səidə Məmmədli, Elizabeth Allen, Karen Bisnauthsing, Yang Xu, Chrysi Sergaki, Marcelle Wood, Marc Delord, Jordana T. Bell, Maria R. Conte, David L. Moyes, Manu Shankar‐Hari, Abdel Douiri, Anna L. Goodman, Debbie L. Shawcross, Simon Goldenberg	2025	3
3	Cefazolin vs. antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis Clinical Microbiology and Infection ·Connor Prosty, Hidemichi Kawanishi, Todd C. Lee, Nick Daneman, Joshua S. Davis, Nynke G L Jager, Nesrin Ghanem‐Zoubi, Anna L. Goodman, Achim J. Kaasch, Ilse J.E. Kouijzer, Brendan McMullan, Emily G. McDonald, Steven Y. C. Tong, Sean Wei Xiang Ong	2025	0
4	Variovorax durovernensis sp. nov., a novel species isolated from an infected prosthetic aortic graft in a human INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY ·Adela Alcolea-Medina, Luke B. Snell, Lara Payne, Christopher Alder, Joshua H. Tandio, Themoula Charalampous, Lei Zhang, John L. Klein, Jonathan D. Edgeworth, Rahul Batra, Anna L. Goodman	2023	6
5	The first reported case of human infection with Variovorax durovernensis; a novel Variovorax sp. Isolated from the prosthetic aortic graft of a shepherd Clinical Infection in Practice ·Lara Payne, Adela Alcolea-Medina, Luke B. Snell, Christopher Alder, Themoula Charalampous, Joshua H. Tandio, Jonathan D. Edgeworth, Rahul Batra, John L. Klein, Anna L. Goodman	2023	0
6	Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation Open Forum Infectious Diseases ·Michael Brown, 慧君叶, H. A. Dickmanns, Megan Plowright, Katie Drury, Joshua Gahir, Hossien Rahimi, Tom Newman, Kate Adams, James Galloway, ธีระพงษ์ ไชยเฉลิมวงศ์, Iya Abdulkarim, Tommy Rampling, Joby Cole, Nicholas Easom, Anna L. Goodman, Michael Marks	2022	2
7	A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship JAC-Antimicrobial Resistance ·Clare Logan, Carolyn Hemsley, A Fife, Jonathan D. Edgeworth, Andrea Mazzella, P. Wade, Anna L. Goodman, Philip Hopkins, Duncan Wyncoll, Jonathan Ball, Tim Planche, Silke Schelenz, Tihana Bicanic	2022	3
8	The Safety of Continued Oral Anticoagulation Therapy in Joint Injections and Aspirations JCR Journal of Clinical Rheumatology ·Jalpa Kotecha, Rana Talib, Beverley J. Hunt, Anna L. Goodman, 本郷雅暉	2022	2
9	Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK Journal of Antimicrobial Chemotherapy ·Nicholas M. Brown, Erwin Brown, (unknown), Anna L. Goodman, Carolyne Horner, Abi Jenkins, (unknown)	2021	27
10	Can PIMS-TS lead to a facial nerve palsy? BMJ Case Reports ·Cornell University, R. Häsler, Mary C. Casahuamán-Urquia, Anna L. Goodman	2021	5
11	COVID-19 Survey in Five National Longitudinal Studies: Waves 1 and 2: User Guide (Version 2) UCL Discovery (University College London) ·Haruta Takahisa, Anna L. Goodman, Débora Dummer Meira, George B. Ploubidis, Meiya Ou, Richard J. Silverwood, Honey A. Mendelson	2020	28
12	Intractable diarrhoea despite immune reconstitution in an HIV positive man Journal of Clinical Virology ·D. Geerardyn, Lyn Ambrose, Daniel P. Webster, Claire Atkinson, Paul Griffiths, Charles Murray, Anna L. Goodman	2015	1
13	Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax Frontiers in Immunology ·Simone C. de Cassan, Ahmad Rushdi Shakri, David Llewellyn, Sean C. Elias, Jee Sun Cho, Anna L. Goodman, Jing Jin, Alexander D. Douglas, Rossarin Suwanarusk, François Nosten, Laurent Rénia, Bruce Russell, Chetan E. Chitnis, Simon J. Draper	2015	29
14	The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment Scientific Reports ·Anna L. Goodman, Emily K. Forbes, Andrew R. Williams, Alexander D. Douglas, Simone C. de Cassan, Karolis Bauza, Sumi Biswas, Matthew D. J. Dicks, David Llewellyn, Anne Moore, Chris J. Janse, Blandine Franke‐Fayard, Sarah C. Gilbert, Adrian V. S. Hill, Richard J. Pleass, Simon J. Draper	2013	27
15	Using inferred probabilities to measure the accuracy of imprecise forecasts Judgment and Decision Making ·Paul J. Lehner, R. H. Fawcett, Leonard Adelman, Anna L. Goodman	2012	7
16	Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice Journal of Antimicrobial Chemotherapy ·Ann Sturdy, Anna L. Goodman, Ricardo J. José, Angela Loyse, Lucía Verdegay, Onn Min Kon, Martin Dedicoat, Thomas S. Harrison, Laurence John, Marc Lipman, Graham Cooke	2011	69
17	Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria Cell Host & Microbe ·Simon J. Draper, Anna L. Goodman, Sumi Biswas, Emily K. Forbes, Anne Moore, Sarah C. Gilbert, Adrian V. S. Hill	2011	0
18	Central airway obstruction caused by a peripheral hamartoma Lung Cancer ·Anna L. Goodman, Mary Falzon, Colin Gelder, Jeremy George	2007	4
19	Use of the Levator Scapulae Muscle Flap in Head and Neck Reconstruction Archives of Otolaryngology - Head and Neck Surgery ·Anna L. Goodman, Paul J. Donald	1990	7
20	The execution unit for the VLSI 432 general data processor IEEE Journal of Solid-State Circuits ·Joel Pinckney, Liyun Mi, Hiroshi Kawamoto, Anna L. Goodman, Jason Howard, I. Hoppe	1981	6

About Anna L. Goodman

Anna L. Goodman is a scholar working on Applied Microbiology and Biotechnology, Microbiology, Virology, Infectious Diseases and Clinical Biochemistry, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (9 papers), Malaria Research and Control (9 papers), COVID-19 Clinical Research Studies (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), HIV Research and Treatment (5 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Virology (158 citations), Public Health, Environmental and Occupational Health (528 citations), Infectious Diseases (286 citations), Immunology (316 citations) and Epidemiology (441 citations). Anna L. Goodman has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Simon J. Draper, Adrian V. S. Hill, Carole A. Long, Sumi Biswas, Alexander D. Douglas, Andrew R. Williams, David Wyllie, Joseph J. Illingworth, Gathoni Kamuyu and Gavin J. Wright. Their work appears in journals such as Clinical Medicine, Infection and Immunity, Vaccine, Nature Communications and American Journal of Tropical Medicine and Hygiene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact